Skip to Main Content

Paper Details

Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia.
Mol Cancer Res
1
2023
AML, Acute Myeloid Leukemia, FLT3, FLT3-ITD, FLT3-ITD (, FLT3-ITD AML, FLT3-mutant AML, Fms-like tyrosine kinase 3, GFI1, H3K9me1, LSD1, LSD1 substrate, MYC, MYC Superenhancer Complex, MYC blood superenhancer, MYC blood-specific superenhancer, MYC target genes, STAT5, acute myeloid leukemia, lysine, lysine-specific demethylase 1, primary AML samples, tyrosine
Apoptosis, Histone Demethylases, Humans, Leukemia, Myeloid, Acute, Mutation, Protein Kinase Inhibitors, STAT5 Transcription Factor, fms-Like Tyrosine Kinase 3
Author NameAffiliation
William M YasharKnight Cancer Institute, Oregon Health & Science University
William M YasharOregon Health & Science University
William M YasharOregon Health & Science University
Brittany M CurtissKnight Cancer Institute, Oregon Health & Science University
Brittany M CurtissOregon Health & Science University
Daniel J ColemanKnight Cancer Institute, Oregon Health & Science University
Jake VanCampenKnight Cancer Institute, Oregon Health & Science University
Jake VanCampenOregon Health & Science University
Garth KongKnight Cancer Institute, Oregon Health & Science University
Garth KongOregon Health & Science University
Jommel MacaraegKnight Cancer Institute, Oregon Health & Science University
Jommel MacaraegOregon Health & Science University
Joseph EstabrookCancer Early Detection Advanced Research Center, Oregon Health & Science University
Emek DemirOregon Health & Science University
Emek DemirOregon Health and Science University
Emek Demir
Nicola LongKnight Cancer Institute, Oregon Health & Science University
Nicola LongOregon Health & Science University
Daniel BottomlyKnight Cancer Institute, Oregon Health & Science University
Daniel BottomlyDepartment of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University
Shannon K McWeeneyKnight Cancer Institute, Oregon Health & Science University
Shannon K McWeeneyDepartment of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University
Jeffrey W TynerOregon Health & Science University
Jeffrey W TynerOregon Health & Science University
Brian J DrukerKnight Cancer Institute, Oregon Health & Science University
Brian J DrukerOregon Health & Science University
Brian J DrukerOregon Health & Science University
Julia E MaxsonKnight Cancer Institute, Oregon Health & Science University
Julia E MaxsonOregon Health & Science University
Theodore P BraunKnight Cancer Institute, Oregon Health & Science University
Theodore P BraunOregon Health & Science University
Theodore P BraunOregon Health & Science University
  • 1 - 32

Datasets

Release 1.2